These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 3217589)
21. [Advances regarding tumor markers in bladder cancer]. Moreno Sierra J; Chicharro Almarza GJ; Torronteras Santiago JM; Ortega Heredia MD; Maestro de las Casas ML; Silmi Moyano A; Resel Estévez L Actas Urol Esp; 1997 Mar; 21(3):195-205. PubMed ID: 9324884 [TBL] [Abstract][Full Text] [Related]
22. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
23. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma]. Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851 [TBL] [Abstract][Full Text] [Related]
24. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction. Del Favero G; Fabris C; Panucci A; Basso D; Plebani M; Baccaglini U; Leandro G; Burlina A; Naccarato R Bull Cancer; 1986; 73(3):251-5. PubMed ID: 3530354 [TBL] [Abstract][Full Text] [Related]
25. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody]. Suzuki H; Teshima K; Noda K Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer. Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383 [TBL] [Abstract][Full Text] [Related]
27. Value of tumour and inflammatory markers in lung cancer. Oremek GM; Sauer-Eppel H; Bruzdziak TH Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794 [TBL] [Abstract][Full Text] [Related]
28. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma. Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125 [TBL] [Abstract][Full Text] [Related]
30. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen]. Bisset JP; Kleisbauer JP; Roux F; Treffot MJ Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886 [TBL] [Abstract][Full Text] [Related]
31. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835 [TBL] [Abstract][Full Text] [Related]
32. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology. Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585 [TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon. von Kleist S; Hesse Y; Kananeeh H Anticancer Res; 1996; 16(4B):2325-31. PubMed ID: 8694564 [TBL] [Abstract][Full Text] [Related]
34. Serum CA 19-9 and CA 50 antigens in hemodialysis patients. Docci D; Pistocchi E; Turci F; Baldrati L; Urbini S; Scaioli S Clin Nephrol; 1987 Apr; 27(4):179-81. PubMed ID: 3472698 [TBL] [Abstract][Full Text] [Related]
35. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging. Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667 [TBL] [Abstract][Full Text] [Related]
36. The tumor markers CEA, TPA and CA 19-9 in gastric cancer. Putzki H; Reichert B; Jablonski M; Heymann H Dtsch Z Verdau Stoffwechselkr; 1988; 48(3-4):145-8. PubMed ID: 3234297 [TBL] [Abstract][Full Text] [Related]
37. Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein. DeSanto NG; Veneroso S; Capodicasa G; Crisci A; Giordano C Am J Nephrol; 1986; 6(6):458-63. PubMed ID: 2436478 [TBL] [Abstract][Full Text] [Related]
38. [A study of sialylated carbohydrate antigen in patients with benign bronchopulmonary disease]. Yokoyama T; Ikedou Y; Kido F; Tanoue S; Tashiro K; Ninomiya H; Rikimaru T; Kajiki A; Takamoto M; Ishibashi T; Oizumi K Nihon Kokyuki Gakkai Zasshi; 1998 Oct; 36(10):851-6. PubMed ID: 9893426 [TBL] [Abstract][Full Text] [Related]